
CureVac N.V. CVAC
Quarterly report 2022-Q2
added 08-18-2022
CureVac N.V. Shares 2011-2026 | CVAC
Annual Shares CureVac N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 186 M | 181 M | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | 181 M | 184 M |
Quarterly Shares CureVac N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 187 M | - | - | - | 184 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 187 M | 184 M | 186 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
103 M | $ 2.08 | -14.4 % | $ 214 M | ||
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
Altimmune
ALT
|
71 M | $ 4.2 | -2.67 % | $ 298 M | ||
|
Apellis Pharmaceuticals
APLS
|
126 M | $ 20.24 | -3.44 % | $ 2.55 B | ||
|
Aptorum Group Limited
APM
|
5.45 M | $ 0.8 | 1.87 % | $ 4.36 M | ||
|
Aprea Therapeutics
APRE
|
3.62 M | $ 0.88 | -3.72 % | $ 3.18 M | ||
|
Aptevo Therapeutics
APVO
|
276 K | $ 7.2 | -1.64 % | $ 1.99 M | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Aquestive Therapeutics
AQST
|
86.7 M | $ 4.1 | 2.37 % | $ 356 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Arcturus Therapeutics Holdings
ARCT
|
27 M | $ 8.35 | 1.46 % | $ 225 M | ||
|
Ardelyx
ARDX
|
241 M | $ 6.37 | -2.75 % | $ 1.54 B | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
argenx SE
ARGX
|
51.1 M | $ 756.71 | -1.33 % | $ 25 B | ||
|
Armata Pharmaceuticals
ARMP
|
36.1 M | $ 10.91 | 1.58 % | $ 394 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
Arcutis Biotherapeutics
ARQT
|
127 M | $ 25.33 | -6.1 % | $ 3.22 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
Artelo Biosciences
ARTL
|
2.02 M | $ 1.15 | -3.36 % | $ 2.32 M | ||
|
Arvinas
ARVN
|
70.9 M | $ 12.97 | -2.3 % | $ 920 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
134 M | $ 61.74 | -2.42 % | $ 8.26 B | ||
|
Ascendis Pharma A/S
ASND
|
54.8 M | $ 231.56 | -0.83 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.39 | -1.63 % | $ 8.16 B | ||
|
Actinium Pharmaceuticals
ATNM
|
30.1 M | $ 1.17 | -0.85 % | $ 35.2 M | ||
|
Atossa Therapeutics
ATOS
|
126 M | $ 4.39 | -0.9 % | $ 553 M | ||
|
Atara Biotherapeutics
ATRA
|
7.49 M | $ 5.01 | -7.47 % | $ 37.5 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
134 M | $ 14.14 | -0.21 % | $ 1.9 B | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.68 | -1.75 % | $ 429 M | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Atea Pharmaceuticals
AVIR
|
84.3 M | $ 4.69 | 0.21 % | $ 395 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
85.3 M | $ 4.54 | 2.44 % | $ 387 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Axon Enterprise
AXON
|
75.7 M | $ 570.5 | 5.18 % | $ 43.2 B | ||
|
Axsome Therapeutics
AXSM
|
49.7 M | $ 162.28 | -0.98 % | $ 8.07 B | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Aytu BioScience
AYTU
|
6.28 M | $ 2.56 | -0.58 % | $ 16.1 M | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B |